<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37458788</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1920</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neuroradiology</Title><ISOAbbreviation>Neuroradiology</ISOAbbreviation></Journal><ArticleTitle>Association between brain and upper cervical spinal cord atrophy assessed by MRI and disease aggressiveness in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1395</StartPage><EndPage>1403</EndPage><MedlinePgn>1395-1403</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00234-023-03191-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To study the relative contributions of brain and upper cervical spinal cord compartmental atrophy to disease aggressiveness in amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-nine ALS patients and 24 age- and gender-matched healthy controls (HC) were recruited. Disease duration and the Revised-ALS Functional Rating Scale (ALSFRS-R) at baseline, 3- and 6-months follow-up were assessed. Patients were clinically differentiated into fast (n=13) and slow (n=16) progressors according to their ALSFRS-R progression rate. Brain grey (GM) and white matter, brainstem sub-structures volumes and spinal cord cross-sectional area (SC-CSA) at C1-C2 vertebral levels were measured from a 3D-T1-weighted MRI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fast progressors showed significant GM, medulla oblongata and SC atrophy compared to HC (p&lt;0.001, p=0.013 and p=0.008) and significant GM atrophy compared to slow progressors (p=0.008). GM volume correlated with the ALSFRS-R progression rate (Rho/p=-0.487/0.007), the ALSFRS-R at 3-months (Rho/p=0.622/0.002), and ALSFRS-R at 6-months (Rho/p=0.407/0.039). Medulla oblongata volume and SC-CSA correlated with the ALSFRS-R at 3-months (Rho/p=0.510/0.015 and Rho/p=0.479/0.024). MRI measures showed high performance to discriminate between fast and slow progressors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggests an association between compartmental atrophy and disease aggressiveness. This result is consistent with the combination of upper and lower motor neuron degeneration as the main driver of disease worsening and severity in ALS. Our study highlights the potential of brain and spinal cord atrophy measured by MRI as biomarker of disease aggressiveness signature.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Mendili</LastName><ForeName>Mohamed Mounir</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France. mm.elmendili@univ-amu.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France. mm.elmendili@univ-amu.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de R&#xe9;sonance Magn&#xe9;tique Biologique et M&#xe9;dicale, CRMBM-CEMEREM, UMR 7339 CNRS - Aix-Marseille Universit&#xe9;, 27 Bd Jean Moulin, 13005, Marseille, France. mm.elmendili@univ-amu.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verschueren</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, H&#xf4;pital de la Timone, Referral Centre for Neuromuscular Diseases and ALS, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranjeva</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guye</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attarian</LastName><ForeName>Shahram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>APHM, H&#xf4;pital de la Timone, Referral Centre for Neuromuscular Diseases and ALS, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix Marseille Univ, INSERM, MMG, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaaraoui</LastName><ForeName>Wafaa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grapperon</LastName><ForeName>Aude-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, CNRS, CRMBM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, Hopital de la Timone, CEMEREM, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, H&#xf4;pital de la Timone, Referral Centre for Neuromuscular Diseases and ALS, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neuroradiology</MedlineTA><NlmUniqueID>1302751</NlmUniqueID><ISSNLinking>0028-3940</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="Y">Cervical Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Atrophy</Keyword><Keyword MajorTopicYN="N">Brain</Keyword><Keyword MajorTopicYN="N">Disease aggressiveness</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>15</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37458788</ArticleId><ArticleId IdType="doi">10.1007/s00234-023-03191-0</ArticleId><ArticleId IdType="pii">10.1007/s00234-023-03191-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clarke JL, Jackson JH (1867) On a case of muscular atrophy, with disease of the spinal cord and medulla oblongata. Med Chir Trans 50:489&#x2013;498. https://doi.org/10.1177/095952876705000122</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/095952876705000122</ArticleId><ArticleId IdType="pubmed">20896302</ArticleId><ArticleId IdType="pmc">2147915</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot J, Joffroy A (1869) Deux cas d'atrophie musculaire progressive avec l&#xe9;sions de la substance grise et de faisceaux ant&#xe9;rolat&#xe9;raux de la moelle &#xe9;pini&#xe8;re. Arch Physiol Norm Pathol 1:354&#x2013;357</Citation></Reference><Reference><Citation>Holmes G (1909) The pathology of amyotrophic lateral sclerosis. Rev Neurol Psychiatr 7:693&#x2013;725</Citation></Reference><Reference><Citation>Sarica A, Cerasa A, Valentino P, Yeatman J, Trotta M, Barone S, Granata A, Nistic&#xf2; R, Perrotta P, Pucci F, Quattrone A (2017) The corticospinal tract profile in amyotrophic lateral sclerosis. Hum Brain Mapp 38(2):727&#x2013;739. https://doi.org/10.1002/hbm.23412</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23412</ArticleId><ArticleId IdType="pubmed">27659483</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal NA, Berry JD, Windebank A et al (2020) Addressing heterogeneity in amyotrophic lateral sclerosis Clinical Trials. Muscle Nerve 62(2):156&#x2013;166. https://doi.org/10.1002/mus.26801</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId><ArticleId IdType="pmc">7496557</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, Gaur N, Roediger A et al (2021) Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum Brain Mapp 42(3):737&#x2013;752. https://doi.org/10.1002/hbm.25258</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25258</ArticleId><ArticleId IdType="pubmed">33103324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieckmann N, Roediger A, Prell T et al (2022) Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness. Neuroimage Clin 36:103162. https://doi.org/10.1016/j.nicl.2022.103162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103162</ArticleId><ArticleId IdType="pubmed">36067613</ArticleId><ArticleId IdType="pmc">9460837</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Agosta F, Riva N et al (2017) Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis. Neuroimage Clin 14(17):145&#x2013;152. https://doi.org/10.1016/j.nicl.2017.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RA, K&#xf6;rner S, Filippini N et al (2014) Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 137(Pt 9):2546&#x2013;2555. https://doi.org/10.1093/brain/awu162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu162</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId><ArticleId IdType="pmc">4132644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng L, Ma H, Zhong J, Shang H, Shi H, Pan P (2015) Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies. Neurobiol Aging 36(12):3288&#x2013;3299. https://doi.org/10.1016/j.neurobiolaging.2015.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.018</ArticleId><ArticleId IdType="pubmed">26362941</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Grapperon AM, Dintrich R et al (2022) Alterations of Microstructure and Sodium Homeostasis in Fast Amyotrophic Lateral Sclerosis Progressors: A Brain DTI and Sodium MRI Study. AJNR Am J Neuroradiol 43(7):984&#x2013;990. https://doi.org/10.3174/ajnr.A7559</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A7559</ArticleId><ArticleId IdType="pubmed">35772800</ArticleId><ArticleId IdType="pmc">9262065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Chipika RH, Finegan E et al (2019) Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. Neuroimage Clin 24:102054. https://doi.org/10.1016/j.nicl.2019.102054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102054</ArticleId><ArticleId IdType="pubmed">31711033</ArticleId><ArticleId IdType="pmc">6849418</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Zhang Q, Duan Q et al (2021) Brainstem Involvement in Amyotrophic Lateral Sclerosis: A Combined Structural and Diffusion Tensor MRI Analysis. Front Neurosci 2(15):675444. https://doi.org/10.3389/fnins.2021.675444</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.675444</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Querin G, Bede P, Pradat PF (2019) Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques. Front Neurol 12(10):350. https://doi.org/10.3389/fneur.2019.00350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00350</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Filippi M (2018) Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother 18(5):395&#x2013;406. https://doi.org/10.1080/14737175.2018.1463160</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1463160</ArticleId><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P (2017) Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol 17(1):73. https://doi.org/10.1186/s12883-017-0854-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId><ArticleId IdType="pmc">5393027</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Lenglet T et al (2017) Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur J Neurol 24(8):1040&#x2013;1046. https://doi.org/10.1111/ene.13329</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13329</ArticleId><ArticleId IdType="pubmed">28586096</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Westeneng HJ et al (2019) Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. Neuroimage Clin 24:101984. https://doi.org/10.1016/j.nicl.2019.101984</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101984</ArticleId><ArticleId IdType="pubmed">31499409</ArticleId><ArticleId IdType="pmc">6734179</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1-2):13&#x2013;21. https://doi.org/10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tustison NJ, Avants BB, Cook PA et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29(6):1310&#x2013;1320. https://doi.org/10.1109/TMI.2010.2046908</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TMI.2010.2046908</ArticleId><ArticleId IdType="pubmed">20378467</ArticleId><ArticleId IdType="pmc">3071855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E (2022) Alzheimer&#x2019;s Disease Neuroimaging Initiative. CAT &#x2013; A Computational Anatomy Toolbox for the Analysis of Structural MRI Data. bioRxiv:495736. https://doi.org/10.1101/2022.06.11.495736</Citation></Reference><Reference><Citation>Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56(3):907&#x2013;922. https://doi.org/10.1016/j.neuroimage.2011.02.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.02.046</ArticleId><ArticleId IdType="pubmed">21352927</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Petracca M, Podranski K, Fleysher L, Cocozza S, Inglese M (2020) SUITer: An Automated Method for Improving Segmentation of Infratentorial Structures at Ultra-High-Field MRI. J Neuroimaging 30(1):28&#x2013;39. https://doi.org/10.1111/jon.12672</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12672</ArticleId><ArticleId IdType="pubmed">31691416</ArticleId></ArticleIdList></Reference><Reference><Citation>Manj&#xf3;n JV, Coup&#xe9; P, Mart&#xed;-Bonmat&#xed; L, Collins DL, Robles M (2010) Adaptive non-local means denoising of MR images with spatially varying noise levels. J Magn Reson Imaging 31(1):192&#x2013;203. https://doi.org/10.1002/jmri.22003</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.22003</ArticleId><ArticleId IdType="pubmed">20027588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros C, De Leener B, Badji A et al (2019) Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. Neuroimage 1(184):901&#x2013;915. https://doi.org/10.1016/j.neuroimage.2018.09.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.09.081</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Seigo M, Saidha S et al (2014Dec) Spinal cord normalization in multiple sclerosis. J Neuroimaging 24(6):577&#x2013;584. https://doi.org/10.1111/jon.12097</Citation></Reference><Reference><Citation>Healy BC, Arora A, Hayden DL et al (2012) Approaches to normalization of spinal cord volume: application to multiple sclerosis. J Neuroimaging 22(3):e12&#x2013;e19. https://doi.org/10.1111/j.1552-6569.2011.00629.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1552-6569.2011.00629.x</ArticleId><ArticleId IdType="pubmed">21854479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahedl M, Tan EL, Chipika RH et al (2023) Brainstem-cortex disconnection in amyotrophic lateral sclerosis: bulbar impairment, genotype associations, asymptomatic changes and biomarker opportunities. J Neurol. https://doi.org/10.1007/s00415-023-11682-6</Citation></Reference><Reference><Citation>El Mendili MM, Cohen-Adad J, Pelegrini-Issac M et al (2014) Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS One 9(4):e95516. https://doi.org/10.1371/journal.pone.0095516</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095516</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId><ArticleId IdType="pmc">3995720</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Li Hi Shing S, Chipika RH et al (2019) Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. Neuroimage Clin 24:102089. https://doi.org/10.1016/j.nicl.2019.102089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102089</ArticleId><ArticleId IdType="pubmed">31795059</ArticleId><ArticleId IdType="pmc">6978214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Devenney E, Dobson-Stone C et al (2014) Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 9(8):e105632. https://doi.org/10.1371/journal.pone.0105632</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105632</ArticleId><ArticleId IdType="pubmed">25144223</ArticleId><ArticleId IdType="pmc">4140802</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Grosskreutz J (2013) The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14(7-8):507&#x2013;515. https://doi.org/10.3109/21678421.2013.812661</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzarotti B, Palesi F, Vitali P et al (2020) Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum. Front Aging Neurosci 26(12):593526. https://doi.org/10.3389/fnagi.2020.593526</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.593526</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Biferi MG, Pradat PF (2022) Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials. J Neuromuscul Dis 9(1):25&#x2013;37. https://doi.org/10.3233/JND-210754</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-210754</ArticleId><ArticleId IdType="pubmed">34864683</ArticleId><ArticleId IdType="pmc">8842771</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J, Atsuta N, Watanabe H et al (2017) Structural MRI correlates of amyotrophic lateral sclerosis progression. J Neurol Neurosurg Psychiatry 88(11):901&#x2013;907. https://doi.org/10.1136/jnnp-2016-314337</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314337</ArticleId><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer T, Schreiber F, Hensiek N et al (2020) The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI. Sci Rep 10(1):1783. https://doi.org/10.1038/s41598-020-58687-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58687-z</ArticleId><ArticleId IdType="pubmed">32020025</ArticleId><ArticleId IdType="pmc">7000761</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LM, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, Fran&#xe7;a MC Jr (2014) Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15(1-2):93&#x2013;97. https://doi.org/10.3109/21678421.2013.852589</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.852589</ArticleId><ArticleId IdType="pubmed">24219347</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri K, Vavasour IM, Abel S et al (2022) Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images. Mult Scler J Exp Transl Clin 8(1):20552173211070760. https://doi.org/10.1177/20552173211070760</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20552173211070760</ArticleId><ArticleId IdType="pubmed">35024164</ArticleId><ArticleId IdType="pmc">8743948</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin M&#xca;, El Mendili MM, Gros C et al (2018) Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis. AJNR Am J Neuroradiol 39(1):184&#x2013;192. https://doi.org/10.3174/ajnr.A5427</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5427</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId><ArticleId IdType="pmc">7410702</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendebourg MJ, Matthias Weigel M, Nicole Naumann N et al (2021) Spinal Cord Cervical and Thoracic Gray Matter Atrophy &#x2013; an emerging imaging surrogate for Amyotrophic Lateral Sclerosis. Neurology 96(15):4099</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>